The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2
- PMID: 22913740
- DOI: 10.1111/j.1472-8206.2012.01071.x
The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2
Abstract
Rhodamine 123 is a fluorescent cationic dye commonly used as a mitochondrial probe and known or suspected to be transported by certain drug membrane transporters. The present study was designed to characterize the putative interactions of rhodamine 123 with human organic cation transporter (OCT) 1 and OCT2. Intracellular uptake of the dye was demonstrated to be enhanced in both hOCT1- and hOCT2-overexpressing HEK293 cells when compared with control HEK293 cells. This increase of rhodamine 123 influxes was found to be a saturable carrier-mediated process, with low K(m) values (K(m) = 0.54 μm and K(m) = 0.61 μm for transport of the dye in hOCT1- and hOCT2-positive HEK293 cells, respectively). Known inhibitors of hOCT1 and hOCT2 activities such as verapamil, amitriptyline, prazosin, and quinine were next demonstrated to decrease rhodamine 123 accumulation in hOCT1- and hOCT2-overexpressing HEK293 cells. In addition, the dye was found to inhibit hOCT1- and hOCT2-mediated uptake of tetraethylammonium (TEA), a model substrate for both hOCT1 and hOCT2; rhodamine 123 appeared nevertheless to be a more potent inhibitor of hOCT1-mediated TEA transport (IC₅₀ = 0.37 μm) than of that mediated by hOCT2 (IC₅₀ = 61.5 μm). Taken together, these data demonstrate that rhodamine 123 is a high-affinity substrate for both hOCT1 and hOCT2. This dye may be therefore useful for fluorimetrically investigating cellular hOCT1 or hOCT2 activity, knowing, however, that other factors potentially contributing to cellular accumulation of rhodamine 123, including mitochondrial membrane potential or expression of the efflux transporter P-glycoprotein, have also to be considered.
Keywords: drug transport; organic cation transporter 1; organic cation transporter 2; rhodamine 123.
© 2012 The Authors Fundamental and Clinical Pharmacology © 2012 Société Française de Pharmacologie et de Thérapeutique.
Similar articles
-
Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.Biochem Pharmacol. 2009 Apr 15;77(8):1429-36. doi: 10.1016/j.bcp.2009.01.010. Epub 2009 Jan 29. Biochem Pharmacol. 2009. PMID: 19426682
-
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.Br J Pharmacol. 2002 Jul;136(6):829-36. doi: 10.1038/sj.bjp.0704785. Br J Pharmacol. 2002. PMID: 12110607 Free PMC article.
-
Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.Am J Physiol Renal Physiol. 2009 Jun;296(6):F1504-13. doi: 10.1152/ajprenal.90754.2008. Epub 2009 Apr 8. Am J Physiol Renal Physiol. 2009. PMID: 19357179
-
Organic Cation Transporter-Mediated Clearance of Cardiovascular Drugs: A Pharmacological Perspective.Am J Ther. 2016 May-Jun;23(3):e855-61. doi: 10.1097/MJT.0000000000000148. Am J Ther. 2016. PMID: 25259955 Review.
-
Role of organic cation transporters in drug-drug interaction.Expert Opin Drug Metab Toxicol. 2015;11(10):1619-33. doi: 10.1517/17425255.2015.1069274. Epub 2015 Jul 24. Expert Opin Drug Metab Toxicol. 2015. PMID: 26206523 Review.
Cited by
-
Modular tissue-in-a-CUBE platform to model blood-brain barrier (BBB) and brain interaction.Commun Biol. 2024 Feb 28;7(1):177. doi: 10.1038/s42003-024-05857-8. Commun Biol. 2024. PMID: 38418614 Free PMC article.
-
Rifabutin but not rifampicin can partly out-balance P-glycoprotein induction by concurrent P-glycoprotein inhibition through high affinity binding to the inhibitory site.Arch Toxicol. 2024 Jan;98(1):223-231. doi: 10.1007/s00204-023-03618-w. Epub 2023 Oct 14. Arch Toxicol. 2024. PMID: 37833491 Free PMC article.
-
The Dysregulated MAD in Mad: A Neuro-theranostic Approach Through the Induction of Autophagic Biomarkers LC3B-II and ATG.Mol Neurobiol. 2023 Sep;60(9):5214-5236. doi: 10.1007/s12035-023-03402-y. Epub 2023 Jun 5. Mol Neurobiol. 2023. PMID: 37273153 Review.
-
Examination of the Effect of Proton Pump Inhibitors on the Anticancer Activity of Oxaliplatin.Cancer Diagn Progn. 2022 Nov 3;2(6):620-626. doi: 10.21873/cdp.10151. eCollection 2022 Nov-Dec. Cancer Diagn Progn. 2022. PMID: 36340458 Free PMC article.
-
The effect of ciprofloxacin on doxorubicin cytotoxic activity in the acquired resistance to doxorubicin in DU145 prostate carcinoma cells.Med Oncol. 2022 Sep 7;39(12):194. doi: 10.1007/s12032-022-01787-9. Med Oncol. 2022. PMID: 36071289
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
